PROM1 and glioma: In addition, γ-secretase inhibitors were reported to reduce the colony forming ability of CD133+ glioma stem cells, but not of CD133- cells.102 However, phase I-II clinical trials showed that inhibitors of NOTCH signaling, while moderately safe, have only minimal to moderate influence on tumor progression, although these studies were not performed in combination with radiation.65–67